Medicine recalls
|
| |
| Australia: Stemetil 5mg tablets: Recall - potential for missing blister sheet |
| |
The Therapeutic Goods Administration (TGA) announced that Sanofi-Aventis Australia is recalling one batch of Stemetil (prochlorperazine maleate) 5 mg tablets (batch number 16N0060, expiry date 06/2018). It has been identified that this medicine may have been dispensed with a missing blister sheet, which means affected packs would not contain the correct number of tablets. Stemetil is used to treat nausea, vomiting and dizziness due to various causes, including migraine (severe headache). There are no issues with the quality, safety or efficacy of Stemetil tablets from the batch involved and no other batches are included in this recall.
Please refer to the following website in TGA for details:
http://www.tga.gov.au/alert/stemetil-5-mg-tablets
In Hong Kong, Stemetil Tablet 5mg (HK-31117) is a pharmaceutical product registered by Sanofi-Aventis Hong Kong Ltd (Sanofi HK), and is a prescription only medicine supplied in a bottle of 250 tablets. As confirmed with Sanofi HK, the affected batch (16N0060) has never been imported into Hong Kong. Hence, the recall in Australia has no impact on the product marketed in Hong Kong.
Ends/Thursday, Jun 1, 2017
Issued at HKT 13:00
|
| |
